GenePlanet is an innovative, high-tech company present in more than 35 countries. It started in 2008 with the dream that more and more people around the globe would have the chance to discover their DNA. They could change old habits, enjoy the benefits of better nutrition and exercise in a bespoke way which facilitates the greatest results.
Everyone’s genetic variations play a massive role in our lives and are responsible for making each one of us unique. We offer DNA tests tailored to individuals because we believe that a personalized approach is the only path to a healthier and more fulfilling life.
With the power of next-generation sequencing (NGS), epigenetic alterations, population-scale clinical studies, and state-of-the-art computer science and data science we combine scientific research with technology to provide best solutions for our clients. Candidate will also have a chance to gain experience in Next-Generation-Sequencing laboratory.
If you’re passionate about healthcare and meet the above qualifications, we encourage you to apply for this exciting opportunity. Please attach your CV in English.
Qualified candidates may be invited for interviews before the application deadline: 15.1.2026.

GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.
With over 15 years of experience in the market, GenePlanet collaborates with over 1000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries.
The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures.
GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts.
With a presence in more than 35 countries worldwide and over 100,000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.